oa Bioengineering and the cardiovascular system

References

1. Citron P, Nerem RM. Bioengineering: 25 years of progress, but still only a beginning. Technol Soc. 2004 26:2–3:415–431
   [Google Scholar]
2. Bergman RM, Nerem RM. The cardiovascular technology industry: past, present, and future. Cardiovasc Eng Technol. 2010 1:1:19–24
   [Google Scholar]
3. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009 6::16
   [Google Scholar]
4. Levesque MJ, Nerem RM. The elongation and orientation of cultured endothelial cells in response to shear stress. ASME J Biomech Eng. 1985 107:4:341–347
   [Google Scholar]
5. Dewey CF Jr, Bussolari SR, Gimbrone MA Jr, Davies PF. The dynamic response of vascular endothelial cells to fluid shear stress. ASME J Biomech Eng. 1981 103::177–185
   [Google Scholar]
6. Conway DE, Williams MR, Eskin SG, McIntire LV. Endothelial cell responses to atheroprone flow are driven by two separate flow components: low time-average shear stress and fluid flow reversal. Am J Physiol Heart Circ Physiol. 2010 298::H367
   [Google Scholar]
7. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011 91::327
   [Google Scholar]
8. Girard PR, Nerem RM. Shear stress modulates endothelial cell morphology and F-actin organization through the regulation of focal adhesion-associated proteins. J Cell Physiol. 1995 163::179–193
   [Google Scholar]
9. DeKeulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res. 1998 82::1094–1101
   [Google Scholar]
10. Johnson TL, Barabino GA, Nerem RM. Engineering more physiologic in vitro models for the study of vascular biology. Prog Pediatr Cardiol. 2006 21::201–210
    [Google Scholar]
11. Ziegler T, Alexander RW, Nerem RM. An endothelial cell-smooth muscle cell co-culture model for use in the investigation of flow effects on vascular biology. Ann Biomed Eng. 1995 23::216–225
    [Google Scholar]
12. Stegemann JP, Nerem RM. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three- dimensional culture. Exp Cell Res. 2003 283::146–155
    [Google Scholar]
13. Dasi LP, Simon HA, Sucosky P, Yoganatha AP. Fluid mechanics of artificial heart valves. Clin Exp Pharmacol Physiol. 2009 36:2:225–237
    [Google Scholar]
14. Holliday CJ, Ankeny RF, Jo H, Nerem RM. Discovery of shear-and side-specific mRNAs and miRNAs in human aortic valvular cells. AJP Heart Circ Physiol. 2011 301:3:H856–H867
    [Google Scholar]
15. Nerem RM, Sambanis A. Tissue engineering: from biology to biological substitute. Tissue Eng. 1995 1::3–13
    [Google Scholar]
16. Badylak SF, Nerem RM. Progress in tissue engineering and regenerative medicine. Proc Natl Acad Sci USA. 2010 107:8:3285–3286
    [Google Scholar]
17. Butcher J, Nerem RM. Valvular endotelial cells and the mechanoregulation of valvular pathology. Phil Trans R Soc Lond Part B. 2007 362:1484:1445–1457
    [Google Scholar]
18. Sacks MS, Schoen FJ, Mayer JE. Bioengineering challenges for heart valve tissue engineering. Ann Rev Biomed Eng. 2009 11::289–313
    [Google Scholar]
19. Schmidt D, Dikman PE, Driessen-Mol A, Stenger R, Mariani C, Puolakka A, Rissanen M, Deichmann T, Odermatt B, Weber B, Emmert MY, Zund G, Baaijens F, Hoerstrup S. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Cell Cardiol. 2010 56:6:510–520
    [Google Scholar]
20. Nerem RM, Ensley AE. The tissue engineering of blood vessels and the heart. Am J Transplant. 2004 4:Supplement 6:36–42
    [Google Scholar]
21. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg. 2005 129::1330
    [Google Scholar]
22. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg. 2010 139:2:431–436
    [Google Scholar]
23. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro . Science. 1999 284:5413:489–493
    [Google Scholar]
24. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, Dibernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begeleman KG, Niklason LE. Readily available tissue-engineered vascular grafts. Sci Transl Med. 2011 3:68:1–11
    [Google Scholar]
25. L'Heureux N, Paquet S, Labbe R, Germain L, Auger F. A completely biological tissue-engineered human blood vessel. FASEB J. 1998 12:1:47–56
    [Google Scholar]
26. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med. 2006 12:3:361–365
    [Google Scholar]
27. Garrido S, McAllister T, Dusserre N, Marini A, L'Heureux N. Haemodialysis access via tissue-engineered vascular graft. Lancet. 2009 374:9685:20
    [Google Scholar]
28. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, Antonelli J, Kocher A, Zembala M, Cierpka L, de la Fuente LM, L'Heureux N. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet. 2009 373:9673:1440–1446
    [Google Scholar]
29. Yacoub MY, Nerem RM. Introduction: bioengineering of the heart. Philos Trans R Soc Lond Part B. 2007 362:1484:1253–1255
    [Google Scholar]
30. Malliaras K, Kreke M, Marban E. The stuttering progress of cell therapy for heart disease. Clin Pharmacol Ther. 2011 90:4:532–541
    [Google Scholar]
31. Simpson D, Liu H, Hwang T, Fan M, Nerem RM, Dudley SC. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. 2007 25::2350–2357
    [Google Scholar]
32. Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM. Stem cells. Lancet. 2005 366::592–602
    [Google Scholar]
33. McCloskey KE, Lyons I, Rao RR, Stice SL, Nerem RM. Purified and proliferating endothelial cells derived and expanded in vitro from embryonic stem cells. Endothelium. 2003 10::329–336
    [Google Scholar]
34. Ahsan T, Nerem RM. Fluid shear stress promotes an endothelial phenotype during early differentiation of embryonic stem cells. Tissue Eng Part A. 2010 16:11:3547–3553
    [Google Scholar]
35. Nerem RM. Regenerative medicine: the emergence of an industry. J R Soc Interface. 2010 7::S771–S775
    [Google Scholar]
36. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med. 2001 344:7:532–533
    [Google Scholar]